Results 21 to 30 of about 2,293 (210)

China special issue on gastrointestinal tumors‐Improved survival after multidisciplinary team decision for patients with advanced gastrointestinal cancer: A multicenter, noninterventional, controlled study

International Journal of Cancer, Volume 153, Issue 11, Page 1885-1893, 1 December 2023., 2023
What's new? Although bringing in specialists from different disciplines to discuss and develop treatment recommendations is generally believed to be beneficial to the patient, the survival benefit of implementing multidisciplinary team recommendations in gastrointestinal cancer is unclear.
Qi Zhang, Ye Zhou, Lijie Song, Weijia Fang, Meng Qiu, Yanhong Gu, Yang Yang, Jingdong Zhang, Jing Liu, Jian Li, Ming Lu, Tianxiao Gong, Xin Wang, Yan Li, Jun Yang, Yingjiang Ye, Lin Shen   +16 more
wiley   +1 more source

Ramucirumab beyond progression plus TAS‐102 in patients with advanced or metastatic esophagogastric adenocarcinoma, after treatment failure on a ramucirumab‐based therapy

International Journal of Cancer, Volume 153, Issue 10, Page 1726-1733, 15 November 2023., 2023
What's new? This multicenter, non‐randomized, open‐label, investigator‐initiated pilot trial evaluated the efficacy of the combination of VEGFR‐targeting antibody ramucirumab beyond progression with TAS‐102 (trifluridine/tipiracil) in advanced esophagogastric adenocarcinoma.
Thorsten Oliver Goetze, Alexander Stein, Sylvie Lorenzen, Timorshah Habibzada, Eray Goekkurt, Peter Herhaus, Maria Loose, Disorn Sookthai, Tanita Brulin, Kristina Ihrig, Claudia Pauligk, Salah‐Eddin Al‐Batran   +11 more
wiley   +1 more source

Krukenberg Tumor

Aziz M, Killeen RB, Carlson K, Kasi A.
europepmc   +3 more sources

Treatments and overall survival in patients with Krukenberg tumor [PDF]

, 2019
BACKGROUND: Krukenberg tumor (KT) is a rare secondary ovarian tumor, primarily localized at the gastrointestinal tract in most cases. KT is related to severe prognosis due to its aggressiveness, diagnostic difficulties and poor treatment efficacy ...
Corcione, Francesco, D'Armiento, Maria, De Luca, Marcello, Insabato, Luigi, Lionetti, Ruggero, Mascolo, Massimo, Raffone, Antonio, Saccone, Gabriele, Travaglino, Antonio, Zullo, Fulvio   +9 more
core   +1 more source

Prognostic factors in Krukenberg tumor [PDF]

, 2019
BACKGROUND: Krukenberg tumor (KT) is a rare secondary ovarian tumor. Little is known about clinicopathologic factors affecting prognosis in KT. OBJECTIVE: To assess the prognostic value of clinicopathologic factors in KT through a systematic review ...
Corcione, F., D'Armiento, M., De Luca, M., Di Cicco, A., Insabato, L., Lionetti, R., Mascolo, M., Raffone, A., Saccone, G., Travaglino, A., Zullo, F.   +10 more
core   +1 more source

Tumor de Krukenberg: a propósito de un caso clínico.

Revista Científica CMDLT, 2023
El tumor de Krukenberg representa entre el 5 % y 30 % de los tumores ováricos metastasico, las principales localizaciones de metástasis al ovario fueron de origen gástrico (67 %), seguido de colon y recto (9 %), mamario (7 %), vesícula y vía biliar.
Carmen Suarez, Betania Cabrita, Alirio Mijares, Diana Perez, Gabriela Marcano   +4 more
doaj   +2 more sources

Goblet cell carcinoid of the appendix [PDF]

, 2005
Background Goblet cell carcinoid (GCC) of the appendix is a rare neoplasm that share histological features of both adenocarcinoma and carcinoid tumor. While its malignant potential remains unclear, GCC's are more aggressive than conventional carcinoid ...
Pahlavan Payam S, Kanthan Rani
core   +2 more sources

Tumor de Krukenberg del Ovario

Revista Colombiana de Obstetricia y Ginecología, 1974
El tumor de Krukenberg del ovario es una entidad poco frecuente entre nosotros; en cinco hospitales del país encontramos una incidencia promedio de 6,63% en relación con los tumores malignos de ovario.
Alberto Duarte Contreras, Luis Fernando Luzardo M.   +1 more
doaj   +1 more source

Design of Allosteric Stimulators of the Hsp90 ATPase as New Anticancer Leads [PDF]

, 2017
Allosteric compounds that stimulate Hsp90 adenosine triphosphatase (ATPase) activity were rationally designed, showing anticancer potencies in the low micromolar to nanomolar range.
Agard, Da, Bernardi, A, Colombo, G. 1., D'Annessa, I, Moroni, E, Pennati, M, Rasola, Andrea, SANCHEZ MARTIN, Carlos, Sattin, S, Tao, J, Zaffaroni, N   +10 more
core   +1 more source

Incidental Krukenberg Tumor During Cesarean Section

Annals of Internal Medicine: Clinical Cases, 2022
We present the case of a 29-year-old woman in her 30th week of pregnancy admitted for preterm contractions. She had an emergent cesarean delivery and was noted to have a large ovarian mass diagnosed on pathology as a Krukenberg tumor.
Victor Delgado-Lazo, Rizwana Syed, Kelley B. Mowatt, Andrea Popescu-Martinez   +3 more
doaj   +1 more source